Pharma and medical devices
Currently the mass production and sale of face masks in the Republic of Belarus is increasing constantly. The masks include those to be used as hygienic (sanitary-hygienic) products in order to prevent (the spread of infectious diseases that pose a danger to public health, including coronavirus COVID-19.
As of 1 January 2019, the list of controlled narcotics, psychotropic substances and their precursors has been amended. The list of such substances and their precursors was adopted by Decree No. 681 of 30 June 1998. As a result of the amendments, several substances were added to List I and II.
List I (prohibited narcotic substances) was supplemented by the following positions:
As of 21 April 2018, developers of pharmaceuticals (the Applicants) are required to follow the adopted procedure if they wish to obtain a permit for a clinical trial for their pharmaceuticals.
The state agency responsible for issuing clinical trial permits is the Ministry of Healthcare of the Russian Federation.
The adopted Guideline has been approved for the use by the authorized bodies of the EAEU member states.
The Guideline applies to dosage forms in which the modification of the rate and (or) the place of release of the active ingredient (active substances) in a definite manner is compared with the standard release dosage forms.